Metabolic dysfunction-associated steatohepatitis (MASH) Clinical Trials in Barcelona
4 recruitingBarcelona, Spain
Showing 1–4 of 4 trials
Recruiting
Phase 3
LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis
Metabolic dysfunction-associated steatohepatitis (MASH)Liver Fibrosis
Boehringer Ingelheim1,800 enrolled526 locationsNCT06632444
Recruiting
Phase 3
A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH
Metabolic Dysfunction-Associated Steatohepatitis (MASH) / Nonalcoholic Steatohepatitis (NASH) With Compensated Cirrhosis
89bio, Inc.762 enrolled303 locationsNCT06419374
Recruiting
Patients' Perspectives on Metabolic Dysfunction-associated Steatohepatitis: a Qualitative Study
Metabolic dysfunction-associated steatohepatitis (MASH)
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau25 enrolled2 locationsNCT07188220
Recruiting
Phase 4
Fibrosis Lessens After Metabolic Surgery
Metabolic dysfunction-associated steatohepatitis (MASH)ObesityNon-Alcoholic Fatty Liver Disease+2 more
Ali Aminian120 enrolled22 locationsNCT06374875